Pharmacogenetics and Age-Related Macular Degeneration
Joint Authors
Schwartz, Stephen G.
Brantley, Milam A.
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-10-20
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Pharmacogenetics seeks to explain interpatient variability in response to medications by investigating genotype-phenotype correlations.
There is a small but growing body of data regarding the pharmacogenetics of both nonexudative and exudative age-related macular degeneration.
Most reported data concern polymorphisms in the complement factor H and age-related maculopathy susceptibility 2 genes.
At this time, the data are not consistent and no definite conclusions may be drawn.
As clinical trials data continue to accumulate, these relationships may become more apparent.
American Psychological Association (APA)
Schwartz, Stephen G.& Brantley, Milam A.. 2011. Pharmacogenetics and Age-Related Macular Degeneration. Journal of Ophthalmology،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-457589
Modern Language Association (MLA)
Schwartz, Stephen G.& Brantley, Milam A.. Pharmacogenetics and Age-Related Macular Degeneration. Journal of Ophthalmology No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-457589
American Medical Association (AMA)
Schwartz, Stephen G.& Brantley, Milam A.. Pharmacogenetics and Age-Related Macular Degeneration. Journal of Ophthalmology. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-457589
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-457589
